EVOQ DART-TQ+
The EVOQ® DART-TQ⁺ is the world's first triple quadrupole MS system specifically designed for DART ion source plug-and-play operation. This innovative system allows for the screening and quantitation of samples with exceptional speed, ultra-high sensitivity, and a reduced environmental impact. If conventional LC-MS workflows are required, you can switch from the integrated DART source to the VIP-HESI source in seconds.
EVOQ® DART-TQ⁺ with fully integrated DART ion source
EVOQ® DART-TQ⁺ with VIP-HESI source
EVOQ® DART-TQ+ ion path
Fully-integrated DART source
Receive your quote directly from the manufacturer.
Addictive!
Toxicology
Bruker's new EVOQ DART-TQ+ is an excellent platform for instant screening and subsequent quantification in a single run using a single setup. It occupies a small footprint and is very adaptable for all workflows and sample types.
Review Date: 16 Jul 2024 | Bruker Daltonics
From rapid chromatography-free screens or chromatography-free quantitation enabled by DART-MS to conventional LC-MS every aspect is designed to deliver exceptional triple quadrupole analytical performance day in, day out.
The EVOQ® DART-TQ⁺ offers unparalleled versatility and efficiency, making it an indispensable tool for laboratories focused on food safety, forensic analysis, and environmental monitoring. Its compact benchtop design ensures ease of use, while its advanced features provide the accuracy and reliability needed to tackle the most challenging analytical tasks.
- First & only fully integrated DART ionization source engineered for Direct Analysis in Real Time Mass Spectrometry
- 1,000 MRMs/second for reliable large screening applications
- Up to 30,000 Da/second scan rate
- EDR™ Electron multiplier detector with on-the-fly multiplier gain optimization for Extended Dynamic Range
- MRM Method Builder - the EVOQ® DART-TQ⁺ autofill function removes the need to know the MRM transition lets the software set up the method and manage the TQ duty cycle.
Accelerate today, expand tomorrow: EVOQ DART-TQ+ featuring ClinMass now and ClinDART just ahead
In this application note, Bruker Applied Mass Spectrometry demonstrates the EVOQ® DART-TQ+, the only instrument that can switch fast and easily between conventional LC-MS and fully integrated chromatography-free DART-MS technologies.
In collaboration with RECIPE Chemical + Instruments GmbH, this system supports both LC-MS-based ClinMass® kits and future chromatography-free DART-MS-based ClinDART kits – offering unmatched flexibility and throughput.
Rapid chromatography-free quantification by DART-MS/MS
Hear from Zahuindanda Aventura and Lukas Brunner as they introduce the power of Direct Analysis in Real Time (DART) to rapidly quantify multiple panels of drugs in plasma and serum. This rapid, chromatography-free approach allows analysis to take less than 30 seconds to maximize throughput whilst minimizing solvent and gas usage.
Bruker set to bring chromatography-free diagnostics to the masses
Jeff Zonderman, Vice President of Bruker Applied Mass Spectrometry, unveils major strides in clinical diagnostics with the acquisition of RECIPE, a leading provider of mass spectrometry diagnostic kits for small molecule analysis. Combined with Bruker’s DART (Direct Analysis in Real Time) technology, this move enables the development of fully integrated, chromatography-free mass spectrometry workflows tailored to clinical laboratories.
These innovations—centered around the EVOQ DART TQ+ system—promise higher throughput, reduced solvent use, and simplified workflows, making mass spectrometry more accessible to a wider range of labs. Clinical areas of focus include therapeutic drug monitoring, toxicology, and drugs of abuse, with Bruker working toward a future where mass spectrometry functions more like a traditional clinical analyzer.
With a proven track record in simplifying complex instrumentation—like the industry-leading MALDI Biotyper—Bruker is once again breaking down barriers to clinical adoption. By removing chromatography from the equation, the company is delivering greener, faster, and easier diagnostics for the real-world needs of today’s laboratories.
Watch to learn how Bruker is reshaping the future of clinical mass spectrometry.
Bruker tackles drugs of abuse and POPs issues
At ASMS 2024, Bruker made two significant new technology announcements in the field of mass spectrometry, introducing products that can be implemented in diverse areas such as drugs of abuse screening, and persistent organic pollutants (POPs) analysis.
Watch Jeffrey Zonderman, Senior Vice President at Bruker introducing the EVOQ™ DART-TQ+, a new high-end triple quad, highlighted as a greener and more efficient alternative to chromatographic methods, to be used for targeted analysis. The ecTOF™, a high-resolution GC-MS, is also introduced, providing a new solution for untargeted high-resolution screening.
This video was filmed at ASMS 2024. Explore our full coverage of this year's conference >>
